Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Trial Profile

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 31 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chimeric antigen receptor T cell therapy Hebei Senlang Biotechnology (Primary)
  • Indications Haematological malignancies; Leukaemia; Lymphoma; Multiple myeloma
  • Focus Therapeutic Use
  • Sponsors Hebei Senlang Biotechnology
  • Most Recent Events

    • 14 Dec 2021 Results (n=64 ) from NCT03173417, NCT02546739, NCT03312205 and NCT03671460; analysing factors associated with efficacy following CD19 CAR-T therapy among B-ALL patients with TP53 mutation/chromosome 17p deletion, presented at the 63rd American Society of Hematology Annual Meeting and Exposition
    • 21 Oct 2017 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top